1. Home
  2. IIPR vs SRPT Comparison

IIPR vs SRPT Comparison

Compare IIPR & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innovative Industrial Properties Inc.

IIPR

Innovative Industrial Properties Inc.

HOLD

Current Price

$54.50

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$17.66

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IIPR
SRPT
Founded
2016
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
2016
2000

Fundamental Metrics

Financial Performance
Metric
IIPR
SRPT
Price
$54.50
$17.66
Analyst Decision
Hold
Hold
Analyst Count
7
24
Target Price
★ $61.45
$21.64
AVG Volume (30 Days)
385.7K
★ 2.5M
Earning Date
11-02-2026
11-05-2026
Dividend Yield
★ 13.93%
N/A
EPS Growth
★ N/A
N/A
EPS
2.39
★ 2.99
Revenue
$265,955,000.00
★ $2,198,237,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.40
N/A
P/E Ratio
$22.87
★ $6.08
Revenue Growth
N/A
★ 15.58
52 Week Low
$44.58
$14.68
52 Week High
$65.38
$24.68

Technical Indicators

Market Signals
Indicator
IIPR
SRPT
Relative Strength Index (RSI) 55.64 46.38
Support Level $54.00 $16.51
Resistance Level $57.85 $18.26
Average True Range (ATR) 1.26 0.93
MACD 0.49 0.14
Stochastic Oscillator 94.01 39.89

Price Performance

Historical Comparison
IIPR
SRPT

About IIPR Innovative Industrial Properties Inc.

Innovative Industrial Properties Inc is a real estate investment trust focused on the acquisition, ownership and management of specialized industrial and commercial properties in the United States. Its properties are prominently leased to state-licensed operators for their regulated cannabis facilities. The company conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by its Operating Partnership, directly or through subsidiaries. Its segments are: Cannabis Portfolio and Life Science Portfolio, with the majority of revenue coming from the Cannabis Portfolio segment, which involves acquiring, developing, and leasing real estate to regulated cannabis operators on long-term triple-net leases.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

Share on Social Networks: